Literature DB >> 16997378

Human papillomavirus and circumcision: a meta-analysis.

Robert S Van Howe1.   

Abstract

BACKGROUND: Determine the relationship of circumcision status to the risk for genital infection with human papillomavirus (HPV).
METHODS: A MEDLINE search and a review of references in published articles were used to identify publications from peer-reviewed journals in Index Medicus with data on circumcision status in patients with and without HPV infections. Inclusion criteria included diagnosis by culture, biopsy, or PCR, determination of circumcision status by physical examination, and multiple site sampling including the shaft of the penis. A meta-analysis was performed with sensitivity analyses.
RESULTS: Sixteen articles contained data on circumcision status in patients with and without HPV infections. Eight studies used accurate diagnostic methods. Only three articles satisfied the strict inclusion criteria. There was no significant association between circumcision status and HPV infection (random-effects model summary effect OR=1.20, 95%CI=0.80-1.79) in these three studies. If the eight studies using accurate diagnostic methods are adjusted for the method of determining circumcision status and failure to sample the penile shaft using meta-regression the summary effects odds ratio is 1.25 (95%CI=0.95-1.67).
CONCLUSIONS: The medical literature does not support the claim that circumcision reduces the risk for genital HPV infection. To correctly assess the risk of HPV infection in circumcised males, the penile shaft needs to be sampled for HPV infection.

Entities:  

Mesh:

Year:  2006        PMID: 16997378     DOI: 10.1016/j.jinf.2006.08.005

Source DB:  PubMed          Journal:  J Infect        ISSN: 0163-4453            Impact factor:   6.072


  16 in total

1.  Routine circumcision: the opposing view.

Authors:  Andrew E Macneily
Journal:  Can Urol Assoc J       Date:  2007-11       Impact factor: 1.862

Review 2.  Is neonatal circumcision clinically beneficial? Argument against.

Authors:  Robert S Van Howe
Journal:  Nat Clin Pract Urol       Date:  2009-01-20

3.  Circumcision and non-HIV sexually transmitted infections.

Authors:  Andrew E Macneily; Kourosh Afshar
Journal:  Can Urol Assoc J       Date:  2011-02       Impact factor: 1.862

4.  Circumcision and human papillomavirus infection in men: a site-specific comparison.

Authors:  B Y Hernandez; L R Wilkens; X Zhu; K McDuffie; P Thompson; Y B Shvetsov; L Ning; M T Goodman
Journal:  J Infect Dis       Date:  2008-03-15       Impact factor: 5.226

5.  Sexually transmitted infections and male circumcision: a systematic review and meta-analysis.

Authors:  Robert S Van Howe
Journal:  ISRN Urol       Date:  2013-04-16

6.  Associations between male anogenital human papillomavirus infection and circumcision by anatomic site sampled and lifetime number of female sex partners.

Authors:  Carrie M Nielson; Melody K Schiaffino; Eileen F Dunne; Jason L Salemi; Anna R Giuliano
Journal:  J Infect Dis       Date:  2009-01-01       Impact factor: 5.226

7.  Foreskin development in 10 421 Chinese boys aged 0-18 years.

Authors:  Chao Yang; Xing Liu; Guang-Hui Wei
Journal:  World J Pediatr       Date:  2009-11-13       Impact factor: 2.764

8.  The Strong Protective Effect of Circumcision against Cancer of the Penis.

Authors:  Brian J Morris; Ronald H Gray; Xavier Castellsague; F Xavier Bosch; Daniel T Halperin; Jake H Waskett; Catherine A Hankins
Journal:  Adv Urol       Date:  2011-05-22

Review 9.  Does Male Circumcision Protect against Sexually Transmitted Infections? Arguments and Meta-Analyses to the Contrary Fail to Withstand Scrutiny.

Authors:  Brian J Morris; Catherine A Hankins; Aaron A R Tobian; John N Krieger; Jeffrey D Klausner
Journal:  ISRN Urol       Date:  2014-05-13

Review 10.  Relationship between circumcision and human papillomavirus infection: a systematic review and meta-analysis.

Authors:  Yi-Ping Zhu; Zhong-Wei Jia; Bo Dai; Ding-Wei Ye; Yun-Yi Kong; Kun Chang; Yue Wang
Journal:  Asian J Androl       Date:  2017 Jan-Feb       Impact factor: 3.285

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.